Concepedia

Alicia Morgan

AM

Statistics

Publications

4

Citations

482

H-Index

4

Active since

2005

Affiliations

Arvinas (United States)(Current)

Yale University

Alicia Morgan is an author at Arvinas (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2005–2024

4

Publications

4

Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1

Andrew P. Crew, Kanak Raina, Hanqing Dong et al. · Journal of Medicinal Chemistry · 2017 · 251 citations · Full text

, , +13

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models

Sheryl M. Gough, John J. Flanagan, Jessica L.F. Teh et al. · Clinical Cancer Research · 2024 · 160 citations · Full text

, , +14

Efficient Synthesis of Immunomodulatory Drug Analogues Enables Exploration of Structure–Degradation Relationships

George M. Burslem, Philipp Ottis, Saul Jaime‐Figueroa et al. · ChemMedChem · 2018 · 55 citations

, , +15

Exploring Alternative Synthetic Routes for the Preparation of Five-Coordinate Diamidoamine Group 4 Metal Complexes

Alicia Morgan, M. Kloskowski, Felix Kalischewski et al. · Organometallics · 2005 · 16 citations

, , +12

1–4 of 4